These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3284065

  • 21. Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.
    Briggs D, Dudley C, Pattison J, Pfeffer P, Salmela K, Rowe P, Tydén G, European Tacrolimus Renal Rejection Study Group.
    Transplantation; 2003 Jun 27; 75(12):2058-63. PubMed ID: 12829912
    [Abstract] [Full Text] [Related]

  • 22. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO, Dias MF, Pacheco-Silva A.
    Clin Transplant; 2004 Aug 27; 18(4):450-5. PubMed ID: 15233825
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
    Häyry P, von Willebrand E, Ahonen J, Eklund B, Salmela K, Höckerstedt K, Pettersson E, Koskimies S.
    Transplant Proc; 1987 Feb 27; 19(1 Pt 2):1650-1. PubMed ID: 3079031
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long-term consequences of different immunosuppressive regimens for renal allografts.
    Isoniemi HM, Ahonen J, Tikkanen MJ, von Willebrand EO, Krogerus L, Eklund BH, Höckerstedt KV, Salmela KE, Häyry PJ.
    Transplantation; 1993 Mar 27; 55(3):494-9. PubMed ID: 8456467
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Renal transplantation in hepatitis B carriers: comparison of azathioprine- and cyclosporine-treated recipients.
    Lai MK, Huang CC, Chu SH, Chuang CK, Fong MT.
    Clin Transpl; 1989 Mar 27; ():281-6. PubMed ID: 2487573
    [Abstract] [Full Text] [Related]

  • 31. Human heart transplantation. Rejection risk factors.
    Foerster A, Abdelnoor M, Frøysaker T, Geiran O, Lindberg H, Ovrum E, Pfeffer P, Thorsby E.
    APMIS Suppl; 1988 Mar 27; 2():160-73. PubMed ID: 3052517
    [Abstract] [Full Text] [Related]

  • 32. Renal allograft biopsy and conversion of cyclosporine to azathioprine.
    Shen SY, Weir MR, Coughlin TR.
    Transplantation; 1989 Feb 27; 47(2):223-9. PubMed ID: 2645702
    [Abstract] [Full Text] [Related]

  • 33. Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.
    Hall BM, Tiller DJ, Duggin GG, Horvath JS, Farnsworth A, May J, Johnson JR, Sheil AG.
    Kidney Int; 1985 Aug 27; 28(2):178-86. PubMed ID: 3914572
    [Abstract] [Full Text] [Related]

  • 34. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
    Hourmant M, Taupin JL, Leymerigie F, Cantarovich D, Soulillou JP.
    Transplant Proc; 1989 Feb 27; 21(1 Pt 2):1589-90. PubMed ID: 2652517
    [No Abstract] [Full Text] [Related]

  • 35. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Am J Kidney Dis; 1987 Jun 27; 9(6):476-84. PubMed ID: 3296744
    [Abstract] [Full Text] [Related]

  • 36. Protective effects of calcium antagonists in human renal transplantation.
    Neumayer HH, Kunzendorf U, Schreiber M.
    Kidney Int Suppl; 1992 May 27; 36():S87-93. PubMed ID: 1377295
    [Abstract] [Full Text] [Related]

  • 37. Distinct phenotypic composition of diffuse interstitial and perivascular focal infiltrates in renal allografts: a morphometric analysis of cellular infiltration under conventional immunosuppressive therapy and under cyclosporine A.
    Guettier C, Nochy D, Hinglais N, Pelletier L, Mandet C, Bedrossian J, Duboust A, Moulonguet Doleris L, Camilleri JP, Bariety J.
    Clin Nephrol; 1988 Aug 27; 30(2):97-105. PubMed ID: 2972428
    [Abstract] [Full Text] [Related]

  • 38. Prevention of delayed graft function in cadaver kidney transplants by diltiazem: outcome of two prospective, randomized clinical trials.
    Neumayer HH, Wagner K.
    J Cardiovasc Pharmacol; 1987 Aug 27; 10 Suppl 10():S170-7. PubMed ID: 2455126
    [Abstract] [Full Text] [Related]

  • 39. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney.
    Leunissen KM, Bosman FT, Nieman FH, Kootstra G, Vromen MA, Noordzij TC, van Hooff JP.
    Transplantation; 1989 Oct 27; 48(4):590-3. PubMed ID: 2799911
    [Abstract] [Full Text] [Related]

  • 40. Serum C-reactive protein concentrations in cyclosporine-treated renal allograft recipients.
    Cohen DJ, Benvenisty AI, Meyer E, Hardy MA.
    Transplantation; 1988 May 27; 45(5):919-22. PubMed ID: 3285537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.